Tilray Brands Strengthens Domestic Lead With Strong Q1 Cannabis Growth

Core Insights - Tilray Brands (TLRY) has solidified its position as the largest legal cannabis company in Canada, reporting a 4% year-over-year increase in Canadian cannabis revenues to $51 million in fiscal Q1 2026, supported by extensive cultivation capacity of approximately 5 million square feet and 210 metric tons of cannabis in production [1][9] - The company has gained market share in the adult-use channel, ranking among the top five licensed producers and achieving the 1 position in several product categories, including pre-rolls, beverages, oils, and chocolate edibles, as well as securing the top rank in flower by the end of the quarter [2][9] - Long-term growth is anticipated due to low household cannabis penetration and potential regulatory improvements, such as updates to excise taxes and expanded medical cannabis distribution [3] Industry Update - Cresco Labs (CRLBF) reported steady operational results in Q3, driven by strong wholesale momentum and expanded cultivation capacity, maintaining leading market shares in key states [4] - Canopy Growth (CGC) showed solid momentum in its Canadian business during fiscal Q2, with improvements in both adult-use and medical cannabis segments, supported by stronger commercial execution and cost-discipline measures [6] Price Performance - Over the past six months, Tilray Brands' shares have increased by 129.1%, significantly outperforming the industry growth of 1.8% and the S&P 500's growth of 18.6% [7] Valuation Metrics - Tilray currently trades at a forward 12-month Price-to-Sales (P/S) ratio of 1.30X, compared to the industry average of 3.16X, indicating a discounted valuation [10]